WASHINGTON — The drug company CEO who raised the price of life-saving EpiPens to an exorbitant $608 for a two-pack is blaming Congress for not overhauling an “outdated” medical system.

“Congress and the leaders of this country need to quit putting their toe in this topic and really fix the system. We have an outdated system, inefficient system,” Mylan CEO Heather Bresch told CNBC on Thursday.

“This isn’t an EpiPen issue. This isn’t a Mylan issue. This is a health care issue … The irony is the system incentivizes higher prices. … There’s no question the system is broken.”

Her father happens to be a member of Congress, Sen. Joe Manchin (D-W.Va.), and he’s getting slammed on Facebook for his daughter’s actions.

When he posted an announcement of a $16 million grant for his state, JoAnn Morrison Morlan wrote: “That’s almost as much as your daughter earns gouging people.”

Hundreds of people lashed out on the senator’s social media page. “You must be so proud to have raised a daughter that is putting millions of Americans lives at risk to line her own pockets. Good job, Dad!,” wrote Marge Araujo.

Another Facebook writer, Bem Au, suggested Manchin’s daughter could cost him re-election in 2018. “Keep ignoring the epipen crisis and you will pay for it at the ballot box.”

The price of EpiPens went from less than $100 in 2008 to more than $600 today, angering families nationwide who buy the injected medicine to stop dangerous allergic reactions, often a danger for their kids.

Under tough criticism, including from Democratic presidential nominee Hillary Clinton, Mylan announced Thursday it will offer a $300 discount to some EpiPen users.

Mylan is a donor to the Clinton Foundation and partnered with the charity in 2009 to make HIV drugs more affordable for patients in developing countries.